Strategies for establishing policy, environmental, and systems-level interventions for managing high blood pressure and high cholesterol in health care settings: A qualitative case study

Preventing Chronic Disease

Volumn 5, Issue 3, 2008, Pages

  Koffman, Dyann Matson ^a   Granade, Sharon A ^b   Anwuri, Victoria V ^a,c  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^b NATIONAL CENTER FOR PREPAREDNESS DETECTION AND CONTROL OF INFECTIOUS DISEASES   (United States)

^c Robert Wood Johnson Foundation Diabetes Initiative   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL PATHWAY; HEALTH CARE DELIVERY; HEALTH CARE FACILITY; HEALTH PROMOTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; METHODOLOGY; ORGANIZATION; ORGANIZATION AND MANAGEMENT; OUTPATIENT DEPARTMENT; QUALITATIVE RESEARCH; UNITED STATES;

CRITICAL PATHWAYS; DELIVERY OF HEALTH CARE; HEALTH FACILITIES; HEALTH PROMOTION; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; ORGANIZATIONAL INNOVATION; OUTPATIENT CLINICS, HOSPITAL; QUALITATIVE RESEARCH; UNITED STATES;

EID: 84978405480     PISSN: 15451151     EISSN: 21665435     Source Type: Journal    
DOI: None     Document Type: Article

References (77)

1. Health, United States, 2006, with chartbook on trends in the health of Americans. Hyattsville (MD): National Center for Health Statistics. http://www.cdc.gov/nchs/data/hus/hus06.pdf. Accessed April 17, 2008.
2. Heart disease and stroke statistics-2007 update. Dallas (TX): American Heart Association; 2006
3. Stamler J, Stamler R, Neaton JD, Wentworth D, Daviglus ML, Garside D, et al Low risk-factor profile and long-term cardiovascular and noncardiovascular mortality and life expectancy: findings for 5 large cohorts of young adult and middle-aged men and women. JAMA 1999;282(21):2012-8.
4. Greenland P, Knoll MD, Stamler J, Neaton JD, Dyer AR, Garside DB, et al Major risk factors as antecedents of fatal and nonfatal coronary heart disease events. JAMA 2003;290(7):891-7.
5. He J, Whelton PK. Elevated systolic blood pressure and risk of cardiovascular and renal disease: overview of evidence from observational epidemiologic studies and randomized controlled trials. Am Heart J 1999;138(3 Pt 2):211-9.
6. Cohen JD. A population-based approach to cholesterol control. Am J Med 1997;102(2A):23-5.
7. Centers for Disease Control and Prevention. State-specific cholesterol screening trends-United States, 1991-1999. MMWR Morb Mortal Wkly Rep 2000;49(33):750-5.
8. Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA 2003;290(2):199-206.
9. Ford ES, Mokdad AH, Giles WH, Mensah GA. Serum total cholesterol concentrations and awareness, treatment, and control of hypercholesterolemia among U.S. adults: findings from the National Health and Nutrition Examination Survey, 1999 to 2000. Circulation 2003;107(17):2185-9.
10. Healthy People 2010: heart disease and stroke. Atlanta (GA): Centers for Disease Control and Prevention. http://www.healthypeople.gov/Document/HTML/Volume1/12Heart.htm#_Toc490544220. Accessed April 17, 2008.
11. Rudd P, Miller NH, Kaufman J, Kraemer HC, Bandura A, Greenwald G, et al Nurse management for hypertension. A systems approach. Am J Hypertens 2004;17(10):921-7.
12. Friedman RH, Kazis LE, Jette A, Smith MB, Stollerman J, Torgerson J, et al A telecommunications system for monitoring and counseling patients with hypertension. Impact on medication adherence and blood pressure control. Am J Hypertens 1996;9(4 Pt 1):285-92.
13. McKenney JM, Munroe WP, Wright JT Jr. Impact of an electronic medication compliance aid on long-term blood pressure control. J Clin Pharmacol 1992;32(3):277-83.
14. Ornstein S, Jenkins RG, Nietert PJ, Feifer C, Roylance LF, Nemeth L, et al A multimethod quality improvement intervention to improve preventive cardiovascular care: a cluster randomized trial. Ann Intern Med 2004;141(7):523-32.
15. Wagner EH, Austin BT, Von Korff M. Organizing care for patients with chronic illness. Milbank Q 1996;74(4):511-44.
16. Matson Koffman DM, Goetzel RZ, Anwuri VV, Shore KK, Orenstein D, LaPier T. Heart healthy and stroke free: successful business strategies to prevent cardiovascular disease. Am J Prev Med 2005;29(5 Suppl 1):113-21.
17. Bodenheimer T, Wagner EH, Grumbach K. Improving primary care for patients with chronic illness: the chronic care model, Part 2. JAMA 2002;288(15):1909-14.
18. McLeroy KR, Bibeau D, Steckler A, Glanz K. An ecological perspective on health promotion programs. Health Educ Q 1988;15(4):351-77.
19. Policy and environmental change: new directions for public health-final report. Washington (DC): Association of State and Territorial Directors of Health Promotion and Public Health Education, U.S. Centers for Disease Control and Prevention; 2001. http://www.activelivingbydesign.org/fileadmin/template/documents/Policy_EnvChange_ASTDHPPHE.pdf. Accessed April 17, 2008.
20. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. [Published erratum in: JAMA 2003;290(2):197.] JAMA 2003;289(19):2560-72.
21. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285(19):2486-97.
22. Pearson TA, Blair SN, Daniels SR, Eckel RH, Fair JM, Fortmann SP, et al AHA guidelines for primary prevention of cardiovascular disease and stroke: 2002 update: consensus panel guide to comprehensive risk reduction for adult patients without coronary or other atherosclerotic vascular diseases. American Heart Association Science Advisory and Coordinating Committee. Circulation 2002;106(3):388-91.
23. Smith SC Jr, Blair SN, Bonow RO, Brass LM, Cerqueira MD, Dracup K, et al AHA/ACC scientific statement: AHA/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology. Circulation 2001;104(13):1577-9.
24. Healthy People 2010: access to quality health services. Atlanta (GA): Centers for Disease Control and Prevention. http://www.healthypeople.gov/document/HTML/volume1/01Access.htm. Accessed April 17, 2008.
25. The chronic care model. Seattle (WA): Improving Chronic Illness Care. http://www.improvingchroniccare.org/index.php?p=The_Chronic_Care_Model&s=2. Accessed April 17, 2008.
26. Ockene JK, McBride PE, Sallis JF, Bonollo DP, Ockene IS. Synthesis of lessons learned from cardiopulmonary preventive interventions in healthcare practice setting. Ann Epidemiol 1997;7(Suppl):S32-45.
27. Anwuri VV, Matson-Koffman DM. Systems-level interventions for high blood pressure and high blood cholesterol control and prevention: a review of effective strategies in healthcare settings. Proceeding of the American Public Health Association 131st Annual Meeting and Exposition. 2003 Nov 17-19; San Francisco, CA.
28. U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. McLean (VA): International Medical Publishing; 1996. http://www.ahrq.gov/clinic/cpsix.htm. Accessed April 17, 2008.
29. U.S. Preventive Services Task Force. Guide to clinical preventive services, 2001-2004. 3rd ed. Rockville (MD): U.S. Department of Health and Human Services, Agency for Healthcare Research and Quality; 2005. http://www.ahrq.gov/clinic/gcpspu.htm#top. Accessed April 17, 2008.
30. O'Connor PJ, Quiter ES, Rush WA, Wiest M, Meland JT, Ryu S. Impact of hypertension guideline implementation on blood pressure control and drug use in primary care clinics. Jt Comm J Qual Improv 1999;25(2):68-77.
31. Borenstein JE, Graber G, Saltiel E, Wallace J, Ryu S, Archi J, et al Physician-pharmacist comanagement of hypertension: a randomized, comparative trial. Pharmacotherapy 2003;23(2):209-16.
32. Stroebel RJ, Broers JK, Houle SK, Scott CG, Naessens JM. Improving hypertension control: a team approach in a primary care setting. Jt Comm J Qual Improv 2000;26(11):623-32.
33. Bozovich M, Rubino CM, Edmunds J. Effect of a clinical pharmacist-managed lipid clinic on achieving National Cholesterol Education Program low-density lipoprotein goals. Pharmacotherapy 2000;20(11):1375-83.
34. Shaffer J, Wexler LF. Reducing low-density lipoprotein cholesterol levels in an ambulatory care system. Results of a multidisciplinary collaborative practice lipid clinic compared with traditional physician-based care. Arch Intern Med 1995;155(21):2330-5.
35. Vivian EM. Improving blood pressure control in a pharmacist-managed hypertension clinic. Pharmacotherapy 2002;22(12):1533-40.
36. Solomon DK, Portner TS, Bass GE, Gourley DR, Gourley GA, Holt JM, et al Clinical and economic outcomes in the hypertension and COPD arms of a multicenter outcomes study. J Am Pharm Assoc (Wash) 1998;38(5):574-85.
37. Bogden PE, Koontz LM, Williamson P, Abbott RD. The physician and pharmacist team. An effective approach to cholesterol reduction. J Gen Intern Med 1997;12(3):158-64.
38. Ellis SL, Carter BL, Malone DC, Billups SJ, Okano GJ, Valuck RJ, et al Clinical and economic impact of ambulatory care clinical pharmacists in management of dyslipidemia in older adults: the IMPROVE study. Impact of Managed Pharmaceutical Care on Resource Utilization and Outcomes in Veterans Affairs Medical Centers. Pharmacotherapy 2000;20(12):150816.
39. Avanzini F, Corsetti A, Maglione T, Alli C, Colombo F, Torri V, et al Simple, shared guidelines raise the quality of antihypertensive treatment in routine care. Am Heart J 2002;144(4):726-32.
40. New JP, Mason JM, Freemantle N, Teasdale S, Wong LM, Bruce NJ, et al Specialist nurse-led intervention to treat and control hypertension and hyperlipidemia in diabetes (SPLINT): a randomized controlled trial. Diabetes Care 2003;26(8):2250-5.
41. Hill MN, Han HR, Dennison CR, Kim MT, Roary MC, Blumenthal RS, et al Hypertension care and control in underserved urban African American men: behavioral and physiologic outcomes at 36 months. Am J Hypertens 2003;16(11 Pt 1):906-13.
42. Ditusa L, Luzier AB, Brady PG, Reinhardt RM, Snyder BD. A pharmacy-based approach to cholesterol management. Am J Manag Care 2001;7(10):973-9.
43. Kiessling A, Henriksson P. Efficacy of case method learning in general practice for secondary prevention in patients with coronary artery disease: randomised controlled study. BMJ 2002;325(7369):877-80.
44. Goldstein MK, Lavori P, Coleman R, Advani A, Hoffman BB. Improving adherence to guidelines for hypertension drug prescribing: cluster-randomized controlled trial of general versus patient-specific recommendations. Am J Manag Care 2005;11(11):677-85.
45. Moher M, Yudkin P, Wright L, Turner R, Fuller A, Schofield T, et al Cluster randomised controlled trial to compare three methods of promoting secondary prevention of coronary heart disease in primary care. BMJ 2001;322(7298):1338.
46. Ho PM, Masoudi FA, Peterson ED, Grunwald GK, Sales AE, Hammermeister KE, et al Cardiology management improves secondary prevention measures among patients with coronary artery disease. J Am Coll Cardiol 2004;43(9):1517-23.
47. Asch SM, Baker DW, Keesey JW, Broder M, Schonlau M, Rosen M, et al Does the collaborative model improve care for chronic heart failure? Med Care 2005;43(7):667-75.
48. Becker DM, Yanek LR, Johnson WR Jr, Garrett D, Moy TF, Reynolds SS, et al Impact of a community-based multiple risk factor intervention on cardiovascular risk in black families with a history of premature coronary disease. Circulation 2005;111(10):1298-304.
49. Bogden PE, Abbott RD, Williamson P, Onopa JK, Koontz LM. Comparing standard care with a physician and pharmacist team approach for uncontrolled hypertension. J Gen Intern Med 1998;13(11):740-5.
50. Erickson SR, Slaughter R, Halapy H. Pharmacists' ability to influence outcomes of hypertension therapy. Pharmacotherapy 1997;17(1):140-7.
51. Zillich AJ, Sutherland JM, Kumbera PA, Carter BL. Hypertension outcomes through blood pressure monitoring and evaluation by pharmacists (HOME study). J Gen Intern Med 2005;20(12):1091-6.
52. Denver EA, Barnard M, Woolfson RG, Earle KA. Management of uncontrolled hypertension in a nurse-led clinic compared with conventional care for patients with type 2 diabetes. Diabetes Care 2003;26(8):2256-60.
53. Okamoto MP, Nakahiro RK. Pharmacoeconomic evaluation of a pharmacist-managed hypertension clinic. Pharmacotherapy 2001;21(11):1337-44.
54. Brown AS, Cofer LA. Lipid management in a private cardiology practice (the Midwest Heart experience). Am J Cardiol 2000;85(3A):18A-22A.
55. Kinn JW, O'Toole MF, Rowley SM, Marek JC, Bufalino VJ, Brown AS. Effectiveness of the electronic medical record in cholesterol management in patients with coronary artery disease (Virtual Lipid Clinic). Am J Cardiol 2001;88(2):163-5, A5.
56. Kinn JW, Marek JC, O'Toole MF, Rowley SM, Bufalino VJ. Effectiveness of the electronic medical record in improving the management of hypertension. J Clin Hypertens (Greenwich) 2002;4(6):415-9.
57. Rogers MA, Small D, Buchan DA, Butch CA, Stewart CM, Krenzer BE, et al Home monitoring service improves mean arterial pressure in patients with essential hypertension. A randomized, controlled trial. Ann Intern Med 2001;134(11):1024-32.
58. Stamos TD, Shaltoni H, Girard SA, Parrillo JE, Calvin JE. Effectiveness of chart prompts to improve physician compliance with the National Cholesterol Education Program guidelines. Am J Cardiol 2001;88(12):1420-3, A8.
59. Montgomery AA, Fahey T, Peters TJ, MacIntosh C, Sharp DJ. Evaluation of computer based clinical decision support system and risk chart for management of hypertension in primary care: randomised controlled trial. BMJ 2000;320(7236):686-90.
60. Bosworth HB, Olsen MK, Gentry P, Orr M, Dudley T, McCant F, et al Nurse administered telephone intervention for blood pressure control: a patient-tailored multifactorial intervention. Patient Educ Couns 2005;57(1):5-14.
61. Bosworth H, Olsen K, Dudley T, Orr M, Goldstein M, Datta S, et al Patient education and provider decision support to control blood pressure in primary care: a cluster randomized trial. Ann Intern Med. In press; 2008.
62. Artinian NT, Washington OG, Templin TN. Effects of home telemonitoring and community-based monitoring on blood pressure control in urban African Americans: a pilot study. Heart Lung 2001;30(3): 191-9.
63. Siskind A, Johnson M, Qureshi A, Solow B, Chesebro D, Oldham N. The impact of automatic prescriptions on reducing low-density lipoprotein cholesterol levels. Eff Clin Pract 2000;3(5):240-6.
64. Khoury AT, Wan GJ, Niedermaier ON, LeBrun B, Stiebeling B, Roth M, et al Improved cholesterol management in coronary heart disease patients enrolled in an HMO. J Healthc Qual 2001;23(2):29-33.
65. Stoddard AM, Palombo R, Troped PJ, Sorensen G, Will JC. Cardiovascular disease risk reduction: the Massachusetts WISEWOMAN project. J Womens Health (Larchmt) 2004;13(5):539-46.
66. Appel LJ, Champagne CM, Harsha DW, Cooper LS, Obarzanek E, Elmer PJ, et al Effects of comprehensive lifestyle modification on blood pressure control: main results of the PREMIER clinical trial. JAMA 2003;289(16):2083-93.
67. Vale MJ, Jelinek MV, Best JD, Dart AM, Grigg LE, Hare DL, et al Coaching patients On Achieving Cardiovascular Health (COACH): a multicenter randomized trial in patients with coronary heart disease. Arch Intern Med 2003;163(22):2775-83.
68. Headrick LA, Speroff T, Pelecanos HI, Cebul RD. Efforts to improve compliance with the National Cholesterol Education Program guidelines. Results of a randomized controlled trial. Arch Intern Med 1992;152(12):2490-6.
69. Kisioglu A, Aslan B, Ozturk M, Aykut M, Ilhan I. Improving control of high blood pressure among middle-aged Turkish women of low socio-economic status through public health training. Croat Med J 2004;45(4):477-82.
70. Lin T, Chen CH, Chou P. Impact of the high-risk and mass strategies on hypertension control and stroke mortality in primary health care. J Hum Hypertens 2004;18(2):97-105.
71. Rachmani R, Slavacheski I, Berla M, Frommer-Shapira R, Ravid M. Treatment of high-risk patients with diabetes: motivation and teaching intervention: a randomized, prospective 8-year follow-up study. J Am Soc Nephrol 2005;16(Suppl 1):S22-6.
72. Davis AM, Vinci LM, Okwuosa TM, Huang ES. Cardiovascular health disparities: a systematic review of health care interventions. Med Care Res Rev 2007;64(5 Suppl):29S-100S.
73. Brinkerhoff RO. The success case method: find out quickly what's working and what's not. San Francisco (CA): Berrett-Koehler Publishers, Inc.; 2003.
74. IHI.org. Testing changes. Cambridge (MA): Institute for Healthcare Improvement. http://ihi.org/IHI/Topics/Improvement/ImprovementMethods/HowToImprove/testingchanges.htm. Accessed April 17, 2008.
75. Hypertension diagnosis and treatment (guideline). Bloomington (MN): Institutes for Clinical Systems Improvement. http://www.icsi.org/hypertension_4/hypertension_diagnosis_and_treatment_4.html. Accessed April 17, 2008.
76. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1997;157:2413-46.
77. DMAA definition of disease management. Washington (DC): DMAA: The Care Continuum Alliance. http://www.dmaa.org/dm_definition.asp. Accessed August 7, 2007.